Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
J Invest Dermatol ; 135(3): 776-785, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25313533

ABSTRACT

Human prolactin-induced protein (PIP) is a major protein found in exocrine fluids such as saliva and sweat. Intriguingly, PIP possesses residues (human PIP (hPIP): PIP (29-63)) that display similarity to the aspartic peptidase candidapepsin. Here, we aimed to determine the effect of PIP as a protease on normal skin structure. Using an adhesive tape-stripping technique, we applied hPIP peptide on the corneocytes of normal-appearing facial skin from infants with eczema and healthy infants and then analyzed the morphological structure of corneocytes with Nile Red fluorescence. We also repeatedly applied the hPIP peptide onto the surface of a three-dimensional (3-D) human skin model and then analyzed any changes to the stratum corneum and epidermis using light microscopy and scanning electron microscopy. In both infant groups, a decrease in hydrophobic lipids from the cornified envelope was observed after treatment with hPIP. The peptide hPIP appeared to digest the fine structure of the stratum corneum and induce a proliferation of epidermal keratinocytes within the 3-D human skin model. Our results suggest that aspartic peptidase of PIP found in sweat or saliva deteriorates the skin barrier in a de novo manner, which potentially leads directly to the proliferation of epidermal keratinocytes without any external antigenic factors.


Subject(s)
Carrier Proteins/pharmacology , Cell Proliferation/drug effects , Epidermis/drug effects , Epidermis/pathology , Glycoproteins/pharmacology , Keratinocytes/pathology , Adult , Case-Control Studies , Cells, Cultured , Dermatitis, Atopic/metabolism , Dermatitis, Atopic/pathology , Eczema/metabolism , Eczema/pathology , Epidermis/metabolism , Humans , Infant , Keratinocytes/metabolism , Keratinocytes/ultrastructure , Lipid Metabolism , Membrane Transport Proteins , Microscopy, Electron, Scanning , Middle Aged , Saliva/enzymology , Sweat/enzymology
2.
PLoS One ; 8(9): e73894, 2013.
Article in English | MEDLINE | ID: mdl-24040108

ABSTRACT

TLR9 is a receptor for oligodeoxynucleotides that contain unmethylated CpG motifs (CpG). Because TLR9 resides in the endoplasmic reticulum during the quiescence state, CpG binding to TLR9 requires membrane trafficking, which includes the maturation of the CpG-containing endosome. In the present study, we examined the role of PIKfyve, a phosphatidylinositol 3-phosphate 5-kinase, in the regulation of TLR9 signaling. The PIKfyve inhibitor YM201636 inhibited co-localization of the CpG-containing endosome with LysoTracker, which stains acidic organelle, and with TLR9. YM201636 increased the co-localization of CpG with the early endosome marker EEA1 but decreased co-localization with the late endosome marker LAMP1. Similar results were obtained in Raw264.7 cells containing shRNA that targets PIKfyve. CpG-mediated phosphorylation but not lipopolysaccharide (LPS)-mediated phosphorylation of IKK, p38 MAPK, JNK and Stat3 was severely impaired by the loss of PIKfyve function. CpG-mediated expression of cytokine mRNA was also decreased in the absence of PIKfyve. These findings demonstrate a novel role of PIKfyve in TLR9 signaling.


Subject(s)
Endosomes/metabolism , Oligodeoxyribonucleotides/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Toll-Like Receptor 9/metabolism , Aminopyridines/pharmacology , Animals , Biological Transport/drug effects , Cell Line , Cytokines/genetics , Cytokines/metabolism , Female , Gene Expression Regulation/drug effects , Gene Knockdown Techniques , Heterocyclic Compounds, 3-Ring/pharmacology , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/metabolism , Mice , Phosphatidylinositol 3-Kinases/genetics , Phosphoinositide-3 Kinase Inhibitors , Protein Binding , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction/drug effects
3.
PLoS One ; 6(10): e26836, 2011.
Article in English | MEDLINE | ID: mdl-22053215

ABSTRACT

Synthetic oligodeoxynucleotides containing unmethylated CpG motifs (CpG) stimulate innate immune responses. Phosphoinositide 3-kinase (PI3K) has been implicated in CpG-induced immune activation; however, its precise role has not yet been clarified. CpG-induced production of IL-10 was dramatically increased in macrophages deficient in PI3Kγ (p110γ(-/-)). By contrast, LPS-induced production of IL-10 was unchanged in the cells. CpG-induced, but not LPS-induced, IL-10 production was almost completely abolished in SCID mice having mutations in DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Furthermore, wortmannin, an inhibitor of DNA-PKcs, completely inhibited CpG-induced IL-10 production, both in wild type and p110γ(-/-) cells. Microscopic analyses revealed that CpG preferentially localized with DNA-PKcs in p110γ(-/-) cells than in wild type cells. In addition, CpG was preferentially co-localized with the acidic lysosomal marker, LysoTracker, in p110γ(-/-) cells, and with an early endosome marker, EEA1, in wild type cells. Over-expression of p110γ in Cos7 cells resulted in decreased acidification of CpG containing endosome. A similar effect was reproduced using kinase-dead mutants, but not with a ras-binding site mutant, of p110γ. Thus, it is likely that p110γ, in a manner independent of its kinase activity, inhibits the acidification of CpG-containing endosomes. It is considered that increased acidification of CpG-containing endosomes in p110γ(-/-) cells enforces endosomal escape of CpG, which results in increased association of CpG with DNA-PKcs to up-regulate IL-10 production in macrophages.


Subject(s)
Class Ib Phosphatidylinositol 3-Kinase/metabolism , DNA-Activated Protein Kinase/metabolism , Interleukin-10/biosynthesis , Intracellular Space/enzymology , Macrophages/enzymology , Oligodeoxyribonucleotides/metabolism , Acids/metabolism , Androstadienes/pharmacology , Animals , Cations , Class Ib Phosphatidylinositol 3-Kinase/deficiency , Endosomes/drug effects , Endosomes/metabolism , Female , Intracellular Space/drug effects , Lipopolysaccharides/pharmacology , Liposomes/metabolism , Macrophages/drug effects , Mice , Mice, Inbred C57BL , Mice, SCID , Protein Transport/drug effects , Wortmannin
4.
J Dermatol ; 38(2): 140-5, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21269309

ABSTRACT

Ninety-two exclusively breast-fed Japanese infants with atopic dermatitis were studied to see whether tree nut-related foods (chocolate and coffee) and fermented foods (cheese, yogurt, bread, soy sauce, miso soup and fermented soy beans) eaten by their mothers affected their skin condition. Of the 92 infants, 67 (73%) showed improvement of skin lesions when their mothers avoided these foods and showed aggravation of skin lesions when these foods were reintroduced. The predominant offending foods were chocolate, yogurt, soy sauce and miso soup. A long-term maternal exclusion of the trigger foods brought about progressive improvement of skin lesions in the majority of the infants. These findings suggest that tree nut-related foods and fermented foods are important offending foods of atopic dermatitis in breast-fed infants.


Subject(s)
Breast Feeding , Cacao/adverse effects , Coffee/adverse effects , Cultured Milk Products/adverse effects , Dermatitis, Atopic/pathology , Food Hypersensitivity/complications , Maternal Nutritional Physiological Phenomena , Dermatitis, Atopic/etiology , Female , Follow-Up Studies , Humans , Infant , Milk, Human/chemistry , Severity of Illness Index
5.
J Dermatol ; 37(5): 475-9, 2010 May.
Article in English | MEDLINE | ID: mdl-20536654

ABSTRACT

We report a case of hyperkeratotic variant of porokeratosis Mibelli with dermal amyloid deposits. A 66-year-old man presented with multiple brownish keratotic lesions on the lower extremities, a verrucous nodule on the third toe of the left foot and brownish verrucous plaques on the buttocks for several years. Histopathological examination of the hyperkeratotic plaque in the right gluteal region revealed extreme hyperkeratosis and cornoid lamella. In the papillary dermis, there were prominent eosinophilic amorphous materials which were positive to Dylon staining. Treatment with oral etretinate resulted in a remission of the skin lesions in this case.


Subject(s)
Amyloidosis/pathology , Porokeratosis/pathology , Aged , Amyloidosis/complications , Buttocks/pathology , Humans , Leg/pathology , Male , Toes/pathology
6.
J Dermatol ; 35(7): 407-12, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18705827

ABSTRACT

Atopic dermatitis is a common inflammatory skin disease that especially affects children and adolescents. Many environmental factors have been recognized as relevant in aggravating skin lesions of the disease. However, it remains to be determined whether foods play a role in worsening of skin lesions in children with atopic dermatitis. In the present study, we investigated whether foods play a role in irregular aggravation of skin lesions in children with the disease. The study population consisted of 69 patients aged 3-15 years with atopic dermatitis. They were hospitalized and open challenge tests were performed with suspected foods. Photographs of representative skin lesion sites were taken at baseline and before and after the challenge. We determined challenge-positive foods by evaluating the comparable before/after challenge photographs. One to three (average, 1.9) challenge-positive foods were confirmed in 52 (75%) of the 69 patients examined. Predominant offending foods were chocolate, cheese and yogurt. Specific immunoglobulin E values to offending foods were mostly negative. We asked patients to exclude challenge-positive foods from their diets. They were then discharged and followed up for 3 months at our outpatient clinic. Exclusion of the offending foods for 3 months brought about a remarkable improvement in the disease. These results suggest that foods play an important role in irregular aggravation of skin lesions in children with atopic dermatitis.


Subject(s)
Dermatitis, Atopic/diet therapy , Dermatitis, Atopic/pathology , Food/adverse effects , Adolescent , Child , Child, Preschool , Cohort Studies , Female , Humans , Male , Severity of Illness Index
7.
Arch Dermatol Res ; 295(11): 459-64, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15014952

ABSTRACT

BACKGROUND: Although both interleukin-4 (IL-4) and IL-13 induce immunoglobulin E (IgE) production in vitro, the relative contribution of the two cytokines in various skin lesions of atopic dermatitis remains unclear. OBJECTIVE: We examined the relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis for IgE production. METHODS: The study group comprised 28 atopic dermatitis patients with serum IgE levels more than 2000 IU/ml. The expression levels of IL-4 mRNA and IL-13 mRNA versus that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were determined using a semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) method in samples of normal-appearing skin from seven patients, very mild lesions from eight patients, subacute lesions from ten patients and lichenified lesions from ten patients with atopic dermatitis, and in samples of normal skin from six healthy control subjects. RESULTS: IL-4 mRNA expression was identified in only two of the eight very mild lesions, one of the ten subacute lesions, and none of the ten lichenified lesions, whereas IL-13 mRNA expression was identified in 27 of the 28 skin lesions of atopic dermatitis. The IL-13 mRNA/GAPDH mRNA ratios (x100) in the subacute lesions (94.4+/-20.6) and lichenified lesions (71.4+/-40.4) were significantly greater than in the skin of healthy controls (13.1+/-17.7; P<0.01, P<0.05, respectively). CONCLUSIONS: Upregulation of IL-13 mRNA in subacute and chronic lesions of atopic dermatitis along with scant expression of IL-4 mRNA suggest that IL-13 is a crucial cytokine in lesional skin.


Subject(s)
Dermatitis, Atopic/immunology , Dermatitis, Atopic/physiopathology , Interleukin-13/genetics , Interleukin-4/genetics , Adult , Chronic Disease , Dermatitis, Atopic/pathology , Female , Gene Expression/immunology , Humans , Immunoglobulin E/blood , Immunohistochemistry , Male , Middle Aged , RNA, Messenger/analysis , Skin/pathology
8.
J Dermatol ; 30(10): 708-12, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14684951

ABSTRACT

Although it is well known that the skin in patients with atopic dermatitis becomes drier in winter, the mechanisms of winter deterioration of dry skin are not fully understood. Our purpose was to determine whether residual washing detergent in cotton clothes plays a role in the winter deterioration of atopic dry skin. We studied 148 Japanese patients with atopic dermatitis who visited our dermatology clinic during winter months. They wore cotton underwear, which they had washed in cold tap water. We examined the distribution of dry skin on their trunks. We then asked them to stop washing their clothes with common anionic, additive-enriched detergents, and to use a nonionic, additive-reduced detergent for a period of two weeks. Photographs of 2 or 3 representative dry skin sites on the trunk were taken before and after the trial. By comparing the before-after trial photographs, the severity of dry skin at the end of the trial was assessed on a 5-point scale ranging from markedly improved to worsened. Of the 148 patients examined, 115 (78%) had widespread or localized dry skin on the trunk. The dryness of the skin was prominent around the shoulders. Of these 115 patients, 87 (76%) showed marked or moderate improvement of dry skin after the two-weeks of use of the nonionic, additive-reduced washing detergent. No patient showed worsening of the dry skin. These results suggest that residues of common washing detergents in cotton underclothes play an important role in the winter deterioration of dry skin in patients with atopic dermatitis who use cold tap water for washing their clothes.


Subject(s)
Clothing/adverse effects , Dermatitis, Atopic/diagnosis , Detergents/adverse effects , Ichthyosis/etiology , Adolescent , Adult , Case-Control Studies , Child , Dermatitis, Atopic/etiology , Female , Humans , Japan , Male , Middle Aged , Risk Assessment , Sampling Studies , Seasons , Severity of Illness Index , Textiles
9.
J Dermatol ; 30(2): 91-7, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12692374

ABSTRACT

Although it is well known that patients with atopic dermatitis often show unpredictable, irregular aggravation of skin lesions, there are no previously published studies examining trigger factors for such unpredictable aggravation. We investigated whether foods play a role in the unpredictable, irregular worsening of atopic dermatitis. The patient group included 195 Japanese adult patients with atopic dermatitis who showed unpredictable, irregular aggravation of skin lesions. They were hospitalized and openly challenged with suspected foods. Photographs of representative skin lesion sites were taken at baseline and before and after the challenge. Challenge-positive foods were determined by evaluating the comparable before-after challenge photographs. One to three (average: 1.7) challenge-positive foods were confirmed in 86 (44%) of the 195 patient examined. Predominant offending foods were chocolate, cheese, coffee, yogurt and some Japanese foods such as glutinous rice cake, soy sauce and fermented soybeans. Specific IgE values to the offending foods were mostly negative. Patients were asked to exclude challenge-positive foods from their diets. They were then discharged and followed up for 3 months at our outpatient clinic. Exclusion of the offending foods for 3 months brought about a progressive improvement of the disease. These results suggest that foods play an important role in unpredictable, irregular aggravation of skin lesions in patients with atopic dermatitis.


Subject(s)
Dermatitis, Atopic/pathology , Food Hypersensitivity/complications , Adolescent , Adult , Dermatitis, Atopic/etiology , Female , Food Hypersensitivity/diagnosis , Humans , Male , Middle Aged
10.
Dermatology ; 206(2): 110-2, 2003.
Article in English | MEDLINE | ID: mdl-12592076

ABSTRACT

BACKGROUND: Although it has been recognized that women with atopic dermatitis often show menstrual-cycle-associated skin deterioration, information about this subject is meager. OBJECTIVE: To clarify the clinical features of the monthly worsening of atopic dermatitis. METHODS: A total of 286 Japanese women with atopic dermatitis were interviewed to see whether the menstrual cycle had any influence upon their skin lesions, and whether they had symptoms of premenstrual syndrome. Patients suffering from monthly skin deterioration were then observed during and after the monthly worsening. RESULTS: Of the 286 patients interviewed, 134 (47%) had monthly skin deterioration, most of which occurred in the premenstrual week. There was individual difference in severity of the monthly skin worsening. All patients with the premenstrual skin aggravation had symptoms of premenstrual syndrome. CONCLUSIONS: Premenstrual worsening of skin lesions occurs in approximately half of women with atopic dermatitis. The premenstrual skin deterioration is related to the premenstrual syndrome.


Subject(s)
Dermatitis, Atopic/pathology , Menstruation , Skin/pathology , Adolescent , Adult , Dermatitis, Atopic/complications , Female , Humans , Middle Aged , Premenstrual Syndrome/complications
11.
J Dermatol ; 29(11): 731-4, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12484436

ABSTRACT

We report a case of erythema gyratum repens (EGR) in a 59-year-old man with inoperable pancreatic cancer and liver metastasis. The patient had a widespread erythema with concentric marginal band spreading in waves over the trunk and extremities. Numerous vesicles were seen on the margin of the erythema. The skin lesions were severely pruritic, and his peripheral blood showed marked eosinophilia. He also had palmoplantar hyperkeratosis. A biopsy specimen of the erythema disclosed spongiosis, microvesicles filled with eosinophils, infiltration of eosinophils into the epidermis, and a perivascular infiltrate in the dermis. The skin lesions and pruritus cleared quickly after the administration of cetirizine hydrochloride.


Subject(s)
Cetirizine/administration & dosage , Erythema Multiforme/diagnosis , Erythema Multiforme/drug therapy , Liver Neoplasms/secondary , Pancreatic Neoplasms/pathology , Paraneoplastic Syndromes/diagnosis , Administration, Oral , Biopsy, Needle , Disease Progression , Fatal Outcome , Humans , Immunohistochemistry , Liver Neoplasms/therapy , Male , Middle Aged , Neoplasm Staging , Palliative Care/methods , Pancreatic Neoplasms/therapy , Severity of Illness Index
12.
J Dermatol Sci ; 30(1): 37-42, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12354418

ABSTRACT

It remains unclear whether an impaired barrier function often seen in areas of normal-appearing skin in patients with active atopic dermatitis (AD) is primary event in nature or secondary to subclinical eczematous change. We then attempted to evaluate the barrier function of normal-appearing skin in both active and healed AD patients, and as well as see whether a subclinical eczematous change exists or not in the normal-appearing skin using a non-invasive method. Transepidermal water loss (TEWL) measurement and exfoliative cytology method for corneal layer were applied in 153 AD patients who have active skin lesions and 29 individuals with completely healed AD for at least 5 years and 40 normal individuals. The TEWL of normal-appearing skin in severe, moderate and mild AD cases was 10.5+/-2.9, 8.3+/-2.4 and 7.3+/-2.1 g/m2 per h, respectively. The TEWL values in severe and moderate cases were significantly higher than the normal controls (6.2+/-1.6 g/m2 per h). However, the TEWL was not deranged in patients with completely healed AD. An exfoliative cytology examination of corneal layer disclosed that patchy parakeratosis appeared in normal-appearing skin in severe, moderate and mild AD cases at a rate of 42, 29 and 19%, respectively. However, no patchy parakeratosis was recognized in patients with completely healed AD. The occurrence of patchy parakeratosis in normal-appearing skin in patients with active AD suggests that an impaired barrier function often seen in normal-appearing skin in AD patients is secondary to subclinical eczematous change in the area.


Subject(s)
Dermatitis, Atopic/pathology , Parakeratosis/pathology , Skin/pathology , Skin/physiopathology , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Parakeratosis/etiology , Reference Values , Skin/cytology , Water Loss, Insensible
13.
Biochem Biophys Res Commun ; 292(3): 776-80, 2002 Apr 05.
Article in English | MEDLINE | ID: mdl-11922633

ABSTRACT

Thromboxane A2 (TXA2) is an arachidonate metabolite which is considered to relate to chronic inflammation in atopic diseases characterized by elevated immunoglobulin E productivity. The elevation of immunoglobulin E levels involves many molecules including interleukin-4 (IL-4) and interleukin-4 receptor alpha chain (IL-4R alpha). To assess whether genetic variants of TXA2 receptor, IL-4 and IL-4R alpha genes relate to the elevation of serum immunoglobulin E levels in patients with atopic dermatitis (AD), we conducted an association study of genetic polymorphisms of TXA2 receptor (795C/T), IL-4 (-589C/T), and IL-4R alpha (Ile50Val) in a Japanese population (n = 789). The TXA2 receptor 795TT genotype strongly related to AD with high serum immunoglobulin E concentrations. AD patients with both TXA2 receptor 795TT genotype and the IL-4R alpha Ile50/Ile50 genotype showed the greatest immunoglobulin E concentrations. These results suggest TXA2 receptor polymorphism strongly interacts with IL-4R alpha polymorphism as a major determinant of high serum immunoglobulin E levels in AD.


Subject(s)
Dermatitis, Atopic/genetics , Immunoglobulin E/blood , Receptors, Interleukin-4/genetics , Receptors, Thromboxane/genetics , Adolescent , Adult , Aged , Child , Dermatitis, Atopic/immunology , Dermatitis, Atopic/physiopathology , Female , Humans , Japan , Male , Middle Aged , Polymorphism, Genetic , Receptors, Interleukin-4/immunology , Receptors, Thromboxane/immunology
14.
Dermatology ; 204(1): 23-8, 2002.
Article in English | MEDLINE | ID: mdl-11834845

ABSTRACT

BACKGROUND: In Japan, a considerable number of adult patients with atopic dermatitis suffer from recalcitrant facial erythema that resists common treatment with topical corticosteroids and antihistamines. OBJECTIVE: Our purpose was to investigate the potential role of sun exposure in the aggravation of these facial lesions. METHODS: The history of photoaggravation was taken from 74 adult patients with atopic dermatitis who suffered from recalcitrant facial erythema. Repeated UVB and UVA phototests were performed in 36 patients. Surface markers of infiltrating cells in UVB-provoked lesions were characterized immunohistochemically. RESULTS: Forty-one of 74 patients experienced an exacerbation of the facial lesions after sun exposure. UVB testing revealed an abnormal, papular response in 14 of 36 patients. All of the 14 patients complained of clinical aggravation after sun exposure. No abnormal reactions were observed at UVA testing. In UVB-provoked lesions, CD4+ cells were predominant to CD8+ cells. CONCLUSION: Exposure to UVB radiation may be responsible for the recalcitrant facial erythema in at least some of the patients with atopic dermatitis.


Subject(s)
Dermatitis, Atopic/pathology , Dermatitis, Atopic/physiopathology , Erythema/pathology , Erythema/physiopathology , Sunlight/adverse effects , Adolescent , Adult , Biopsy, Needle , Facial Dermatoses/pathology , Facial Dermatoses/physiopathology , Female , Follow-Up Studies , Humans , Immunohistochemistry , Male , Middle Aged , Risk Assessment , Risk Factors , Severity of Illness Index , Skin/drug effects , Skin/radiation effects , Skin Tests/methods , Sunscreening Agents/pharmacology , Ultraviolet Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...